Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Bioenvision Inc (BIVN) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data at Bioenvision Inc. Table 2 shows the detailed insider transactions. The reporting company's CIK number is 1028205.
Total stock buying since 2005: $48,757,206.
Total stock sales since 2005: $4,614,466.
Total stock option exercises since 2005: $326,600.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2007 | 8,706,644 | $48,757,206 | 0 | $0 | 0 | $0 |
| 2006 | 0 | $0 | 480,000 | $3,906,147 | 285,000 | $326,600 |
| 2005 | 0 | $0 | 80,000 | $708,319 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2007-07 | 8,706,644 | $48,757,206 | 0 | $0 | 0 | $0 |
| 2006-04 | 0 | $0 | 0 | $0 | 110,000 | $80,850 |
| 2006-03 | 0 | $0 | 300,000 | $2,362,267 | 0 | $0 |
| 2006-02 | 0 | $0 | 180,000 | $1,543,880 | 175,000 | $245,750 |
| 2005-09 | 0 | $0 | 80,000 | $708,319 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2007-07-10 | Wichita Bio Corp (10% Owner) | Buy | 8,706,644 | 5.60 | 48,757,206 |
| 2006-04-03 | Luci David P (CFO & Gen. Counsel) | Option Ex | 110,000 | .73 | 80,850 |
| 2006-03-09 | Nelson Thomas Scott (Director) | Sale | 37,500 | 7.71 | 289,162 |
| 2006-03-08 | Nelson Thomas Scott (Director) | Sale | 52,500 | 7.69 | 403,620 |
| 2006-03-06 | Griffith Hugh (Chief Operating Officer) | Sale | 60,000 | 7.93 | 475,620 |
| 2006-03-06 | Luci David P (CFO & Gen. Counsel) | Sale | 135,000 | 7.96 | 1,074,600 |
| 2006-03-06 | Wood Christopher B (Chairman, CEO) | Sale | 15,000 | 7.95 | 119,265 |
| 2006-02-28 | Griffith Hugh (Chief Operating Officer) | Sale | 65,000 | 8.57 | 557,115 |
| 2006-02-28 | Abercrombie Ian (Sales Manager (Europe)) | Sale | 50,000 | 8.59 | 429,650 |
| 2006-02-28 | Luci David P (CFO & Gen. Counsel) | Sale | 65,000 | 8.57 | 557,115 |
| 2006-02-27 | Griffith Hugh (Chief Operating Officer) | Option Ex | 125,000 | 1.45 | 181,250 |
| 2006-02-27 | Abercrombie Ian (Sales Manager (Europe)) | Option Ex | 50,000 | 1.29 | 64,500 |
| 2005-09-12 | Nelson Thomas Scott (Director) | Sale | 80,000 | 8.85 | 708,319 |
Insider trading activities including stock purchases, stock sales, and option exercises of BIVN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Bioenvision Inc (symbol BIVN, CIK number 1028205) see the Securities and Exchange Commission (SEC) website.